A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Ocular Hypertension
Related studies linked through entity extraction aliases.
Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Efficacy of Changing to TRAVATAN® From Prior Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Travacom Post Marketing Surveillance Study
- Status
- WITHDRAWN
- Phase
- PHASE4
Efficacy of Changing to TRAVATAN® From Prior Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect
- Status
- COMPLETED
- Phase
- NA
Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- N/A
AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines
- Status
- UNKNOWN
- Phase
- N/A
Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients
- Status
- UNKNOWN
- Phase
- N/A
Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)
- Status
- COMPLETED
- Phase
- PHASE4
Travoprost 3-Month Safety and Efficacy Study
- Status
- COMPLETED
- Phase
- PHASE3
Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%
- Status
- WITHDRAWN
- Phase
- PHASE3
Ocular Hypertension And Yoga Study
- Status
- WITHDRAWN
- Phase
- NA
Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost
- Status
- UNKNOWN
- Phase
- NA
A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada
- Status
- COMPLETED
- Phase
- PHASE4
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma
- Status
- COMPLETED
- Phase
- PHASE4